Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Amyloidosis | 53 | 2024 | 885 | 18.450 |
Why?
|
Cardiomyopathies | 71 | 2024 | 2067 | 12.460 |
Why?
|
Myocardial Perfusion Imaging | 89 | 2024 | 669 | 11.960 |
Why?
|
Amyloid Neuropathies, Familial | 22 | 2024 | 187 | 8.310 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 68 | 2024 | 1145 | 5.340 |
Why?
|
Positron-Emission Tomography | 104 | 2024 | 6547 | 5.000 |
Why?
|
Prealbumin | 31 | 2024 | 266 | 4.900 |
Why?
|
Coronary Artery Disease | 104 | 2024 | 6544 | 4.640 |
Why?
|
Cardiology | 38 | 2024 | 1702 | 4.520 |
Why?
|
Ethylene Glycols | 8 | 2024 | 196 | 3.990 |
Why?
|
Nuclear Medicine | 21 | 2024 | 261 | 3.970 |
Why?
|
Radiopharmaceuticals | 37 | 2024 | 2699 | 3.570 |
Why?
|
Radionuclide Imaging | 20 | 2024 | 1978 | 3.320 |
Why?
|
Coronary Circulation | 44 | 2024 | 1602 | 3.220 |
Why?
|
Aniline Compounds | 8 | 2024 | 1075 | 2.960 |
Why?
|
Myocardium | 30 | 2024 | 4760 | 2.690 |
Why?
|
Heart | 29 | 2023 | 4414 | 2.660 |
Why?
|
Rubidium Radioisotopes | 20 | 2018 | 101 | 2.460 |
Why?
|
Technetium Tc 99m Pyrophosphate | 7 | 2024 | 54 | 2.400 |
Why?
|
Exercise Test | 39 | 2024 | 2180 | 2.320 |
Why?
|
Fluorodeoxyglucose F18 | 20 | 2024 | 2024 | 2.300 |
Why?
|
Fractional Flow Reserve, Myocardial | 21 | 2024 | 345 | 2.150 |
Why?
|
Echocardiography | 18 | 2024 | 5045 | 2.150 |
Why?
|
Sarcoidosis | 16 | 2019 | 532 | 2.070 |
Why?
|
Cardiac Imaging Techniques | 11 | 2023 | 280 | 1.970 |
Why?
|
Heart Failure | 30 | 2024 | 11840 | 1.950 |
Why?
|
Myocardial Ischemia | 21 | 2023 | 2128 | 1.930 |
Why?
|
Predictive Value of Tests | 43 | 2024 | 15398 | 1.800 |
Why?
|
Heart Diseases | 13 | 2022 | 2821 | 1.690 |
Why?
|
Diphosphates | 6 | 2023 | 91 | 1.610 |
Why?
|
Consensus | 16 | 2024 | 3202 | 1.600 |
Why?
|
Magnetic Resonance Imaging, Cine | 11 | 2024 | 1094 | 1.590 |
Why?
|
Amyloid | 11 | 2024 | 853 | 1.560 |
Why?
|
Ventricular Function, Left | 19 | 2024 | 3928 | 1.420 |
Why?
|
Technetium | 9 | 2023 | 326 | 1.380 |
Why?
|
Cardiovascular Infections | 3 | 2024 | 11 | 1.360 |
Why?
|
Vasodilator Agents | 15 | 2021 | 988 | 1.350 |
Why?
|
Tomography, X-Ray Computed | 46 | 2024 | 20659 | 1.320 |
Why?
|
Coronary Angiography | 37 | 2024 | 4493 | 1.320 |
Why?
|
Societies, Medical | 21 | 2024 | 3956 | 1.280 |
Why?
|
Humans | 315 | 2024 | 765968 | 1.160 |
Why?
|
Stroke Volume | 22 | 2023 | 5596 | 1.100 |
Why?
|
Endocarditis | 4 | 2024 | 350 | 1.080 |
Why?
|
Fluorine Radioisotopes | 2 | 2020 | 397 | 1.080 |
Why?
|
Diagnostic Techniques, Cardiovascular | 4 | 2021 | 153 | 1.020 |
Why?
|
Prognosis | 65 | 2024 | 29922 | 1.010 |
Why?
|
Hyperemia | 4 | 2017 | 224 | 0.970 |
Why?
|
Delphi Technique | 5 | 2024 | 893 | 0.970 |
Why?
|
Image Interpretation, Computer-Assisted | 11 | 2018 | 3356 | 0.960 |
Why?
|
American Heart Association | 3 | 2021 | 1047 | 0.950 |
Why?
|
Image Enhancement | 10 | 2017 | 2858 | 0.910 |
Why?
|
Coronary Vessels | 14 | 2023 | 3096 | 0.900 |
Why?
|
Immunoglobulin Light Chains | 3 | 2024 | 290 | 0.880 |
Why?
|
Radiation Dosage | 9 | 2021 | 1944 | 0.840 |
Why?
|
Perfusion | 17 | 2024 | 1407 | 0.830 |
Why?
|
Molecular Imaging | 6 | 2023 | 822 | 0.810 |
Why?
|
Aged | 106 | 2024 | 171117 | 0.770 |
Why?
|
Tellurium | 2 | 2020 | 24 | 0.750 |
Why?
|
Heart Transplantation | 8 | 2024 | 3310 | 0.750 |
Why?
|
Ventricular Dysfunction, Left | 12 | 2020 | 2136 | 0.740 |
Why?
|
Cadmium | 3 | 2022 | 218 | 0.720 |
Why?
|
Image Processing, Computer-Assisted | 16 | 2024 | 8923 | 0.720 |
Why?
|
Amyloidogenic Proteins | 3 | 2023 | 153 | 0.720 |
Why?
|
Coronavirus Infections | 8 | 2020 | 3100 | 0.710 |
Why?
|
Pneumonia, Viral | 8 | 2020 | 3223 | 0.700 |
Why?
|
Pandemics | 17 | 2024 | 8703 | 0.680 |
Why?
|
Middle Aged | 118 | 2024 | 223009 | 0.670 |
Why?
|
Purines | 2 | 2013 | 615 | 0.640 |
Why?
|
Ventricular Dysfunction, Right | 2 | 2024 | 645 | 0.640 |
Why?
|
Male | 140 | 2024 | 363698 | 0.630 |
Why?
|
Leukocytes | 2 | 2024 | 2027 | 0.630 |
Why?
|
Laboratories, Hospital | 1 | 2020 | 193 | 0.630 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2024 | 1736 | 0.620 |
Why?
|
Subtraction Technique | 6 | 2013 | 512 | 0.620 |
Why?
|
Aortitis | 2 | 2016 | 76 | 0.600 |
Why?
|
Myocarditis | 4 | 2023 | 802 | 0.600 |
Why?
|
Female | 143 | 2024 | 396112 | 0.600 |
Why?
|
Microcirculation | 9 | 2023 | 1280 | 0.590 |
Why?
|
Zinc | 3 | 2022 | 675 | 0.590 |
Why?
|
Magnetic Resonance Imaging | 17 | 2024 | 36532 | 0.580 |
Why?
|
Reproducibility of Results | 27 | 2024 | 20124 | 0.540 |
Why?
|
Women's Health | 2 | 2016 | 2084 | 0.530 |
Why?
|
Echocardiography, Doppler | 1 | 2020 | 899 | 0.520 |
Why?
|
Patient-Centered Care | 5 | 2021 | 1458 | 0.510 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2022 | 845 | 0.510 |
Why?
|
Microvessels | 3 | 2015 | 591 | 0.510 |
Why?
|
Registries | 24 | 2024 | 8297 | 0.490 |
Why?
|
Practice Guidelines as Topic | 10 | 2021 | 7425 | 0.480 |
Why?
|
Peptide Fragments | 2 | 2024 | 5125 | 0.470 |
Why?
|
Heart Atria | 4 | 2021 | 1363 | 0.470 |
Why?
|
Biopsy | 8 | 2021 | 6763 | 0.470 |
Why?
|
Heart Ventricles | 7 | 2024 | 3832 | 0.470 |
Why?
|
Dementia | 2 | 2020 | 2744 | 0.470 |
Why?
|
Pericarditis | 1 | 2016 | 137 | 0.460 |
Why?
|
Cardiovascular System | 2 | 2021 | 841 | 0.450 |
Why?
|
Diagnostic Imaging | 10 | 2020 | 3529 | 0.450 |
Why?
|
Dipyridamole | 2 | 2011 | 137 | 0.440 |
Why?
|
Aortic Valve Stenosis | 3 | 2022 | 2023 | 0.440 |
Why?
|
Ammonia | 6 | 2023 | 244 | 0.440 |
Why?
|
Myocardial Infarction | 13 | 2024 | 11499 | 0.430 |
Why?
|
Evidence-Based Medicine | 8 | 2021 | 3685 | 0.430 |
Why?
|
Technetium Tc 99m Sestamibi | 9 | 2022 | 185 | 0.430 |
Why?
|
Cardiovascular Diseases | 12 | 2022 | 15652 | 0.420 |
Why?
|
Risk Assessment | 30 | 2024 | 24282 | 0.410 |
Why?
|
Medical Informatics | 1 | 2020 | 745 | 0.400 |
Why?
|
Adenosine A2 Receptor Agonists | 1 | 2012 | 31 | 0.400 |
Why?
|
Pyrazoles | 2 | 2013 | 2033 | 0.390 |
Why?
|
Societies, Scientific | 1 | 2013 | 221 | 0.390 |
Why?
|
Heart Neoplasms | 2 | 2019 | 375 | 0.360 |
Why?
|
Heart Defects, Congenital | 2 | 2019 | 4697 | 0.350 |
Why?
|
Myocardial Revascularization | 4 | 2014 | 793 | 0.340 |
Why?
|
Laboratories | 4 | 2022 | 462 | 0.340 |
Why?
|
Preventive Health Services | 1 | 2015 | 570 | 0.340 |
Why?
|
Sensitivity and Specificity | 18 | 2024 | 14652 | 0.340 |
Why?
|
United States | 26 | 2024 | 72903 | 0.340 |
Why?
|
Coronary Disease | 8 | 2019 | 5912 | 0.340 |
Why?
|
Aged, 80 and over | 27 | 2024 | 59489 | 0.340 |
Why?
|
Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography | 2 | 2020 | 6 | 0.330 |
Why?
|
Prospective Studies | 21 | 2024 | 54802 | 0.330 |
Why?
|
Paraganglioma, Extra-Adrenal | 1 | 2009 | 47 | 0.310 |
Why?
|
Risk Factors | 37 | 2024 | 74840 | 0.310 |
Why?
|
Ventricular Remodeling | 3 | 2022 | 1272 | 0.300 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2334 | 0.300 |
Why?
|
Stress, Physiological | 3 | 2018 | 1402 | 0.300 |
Why?
|
Military Personnel | 1 | 2017 | 1252 | 0.300 |
Why?
|
Calcinosis | 3 | 2012 | 1479 | 0.300 |
Why?
|
Blood Flow Velocity | 5 | 2017 | 1381 | 0.290 |
Why?
|
Technetium Tc 99m Medronate | 2 | 2018 | 134 | 0.290 |
Why?
|
Hypertrophy, Left Ventricular | 3 | 2023 | 855 | 0.290 |
Why?
|
Unnecessary Procedures | 3 | 2015 | 416 | 0.290 |
Why?
|
Decision Making | 6 | 2015 | 3965 | 0.280 |
Why?
|
Coronary Stenosis | 7 | 2018 | 800 | 0.280 |
Why?
|
Paraganglioma | 1 | 2009 | 143 | 0.280 |
Why?
|
Ethics, Medical | 3 | 2015 | 783 | 0.260 |
Why?
|
Radioisotopes | 2 | 2020 | 495 | 0.250 |
Why?
|
Forecasting | 3 | 2015 | 2936 | 0.250 |
Why?
|
Organotechnetium Compounds | 3 | 2020 | 134 | 0.250 |
Why?
|
Adenosine | 3 | 2011 | 806 | 0.250 |
Why?
|
Atherosclerosis | 2 | 2021 | 3424 | 0.250 |
Why?
|
Time Factors | 16 | 2024 | 40065 | 0.240 |
Why?
|
Cause of Death | 6 | 2018 | 3708 | 0.240 |
Why?
|
Quality Control | 4 | 2020 | 837 | 0.240 |
Why?
|
Prosthesis-Related Infections | 2 | 2024 | 496 | 0.240 |
Why?
|
Contrast Media | 3 | 2021 | 5329 | 0.240 |
Why?
|
Blood Pressure | 5 | 2016 | 8532 | 0.240 |
Why?
|
Heart Rate | 3 | 2014 | 4204 | 0.230 |
Why?
|
Early Diagnosis | 2 | 2020 | 1187 | 0.230 |
Why?
|
Retrospective Studies | 30 | 2024 | 81514 | 0.230 |
Why?
|
Angina, Unstable | 2 | 2019 | 893 | 0.230 |
Why?
|
Echocardiography, Stress | 1 | 2005 | 137 | 0.220 |
Why?
|
Perfusion Imaging | 2 | 2020 | 193 | 0.220 |
Why?
|
Patient Selection | 5 | 2022 | 4255 | 0.220 |
Why?
|
Chest Pain | 4 | 2021 | 1100 | 0.210 |
Why?
|
Regional Blood Flow | 2 | 2018 | 1478 | 0.210 |
Why?
|
Multiple Myeloma | 1 | 2021 | 5197 | 0.200 |
Why?
|
Quality of Life | 1 | 2024 | 13462 | 0.200 |
Why?
|
Cohort Studies | 13 | 2023 | 41649 | 0.200 |
Why?
|
Systemic Vasculitis | 1 | 2023 | 36 | 0.200 |
Why?
|
Troponin I | 1 | 2007 | 655 | 0.200 |
Why?
|
Severity of Illness Index | 11 | 2024 | 15880 | 0.200 |
Why?
|
Calcium | 4 | 2020 | 5767 | 0.200 |
Why?
|
Radiation Protection | 2 | 2016 | 424 | 0.190 |
Why?
|
Electrocardiography | 10 | 2015 | 6404 | 0.190 |
Why?
|
Hypertension | 5 | 2024 | 8626 | 0.190 |
Why?
|
Diabetic Angiopathies | 2 | 2019 | 805 | 0.190 |
Why?
|
Electric Countershock | 1 | 2024 | 534 | 0.180 |
Why?
|
Bone and Bones | 2 | 2024 | 2554 | 0.180 |
Why?
|
Sodium Fluoride | 1 | 2021 | 60 | 0.180 |
Why?
|
Medicare | 1 | 2019 | 6823 | 0.180 |
Why?
|
Adult | 30 | 2022 | 223044 | 0.180 |
Why?
|
Longitudinal Studies | 4 | 2024 | 14751 | 0.180 |
Why?
|
Prevalence | 8 | 2022 | 15842 | 0.170 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2024 | 2310 | 0.170 |
Why?
|
Awards and Prizes | 2 | 2022 | 364 | 0.170 |
Why?
|
Tomography, Emission-Computed | 1 | 2003 | 1006 | 0.170 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2005 | 521 | 0.170 |
Why?
|
Follow-Up Studies | 18 | 2022 | 39193 | 0.170 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5370 | 0.160 |
Why?
|
Mediastinum | 1 | 2021 | 271 | 0.160 |
Why?
|
Vasodilation | 4 | 2012 | 970 | 0.160 |
Why?
|
Gamma Cameras | 1 | 2019 | 35 | 0.160 |
Why?
|
Thallium Radioisotopes | 1 | 2019 | 135 | 0.160 |
Why?
|
Death, Sudden, Cardiac | 4 | 2018 | 1568 | 0.160 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2023 | 3672 | 0.160 |
Why?
|
General Practitioners | 1 | 2020 | 105 | 0.160 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2019 | 84 | 0.160 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2020 | 193 | 0.160 |
Why?
|
Software | 6 | 2021 | 4462 | 0.160 |
Why?
|
Health Services Accessibility | 1 | 2016 | 5508 | 0.150 |
Why?
|
Cardiovascular Agents | 2 | 2017 | 851 | 0.150 |
Why?
|
Survival Rate | 7 | 2019 | 12795 | 0.150 |
Why?
|
Knowledge | 1 | 2020 | 178 | 0.150 |
Why?
|
Finland | 1 | 2019 | 608 | 0.150 |
Why?
|
Exercise | 2 | 2013 | 5937 | 0.150 |
Why?
|
Plaque, Amyloid | 1 | 2022 | 772 | 0.150 |
Why?
|
Receptors, Somatostatin | 1 | 2019 | 138 | 0.150 |
Why?
|
Echocardiography, Transesophageal | 1 | 2024 | 1093 | 0.150 |
Why?
|
Cardiology Service, Hospital | 1 | 2020 | 242 | 0.150 |
Why?
|
Parotid Gland | 1 | 2019 | 177 | 0.150 |
Why?
|
Thoracic Neoplasms | 1 | 2020 | 267 | 0.150 |
Why?
|
Pilot Projects | 3 | 2023 | 8733 | 0.140 |
Why?
|
Death Certificates | 1 | 2018 | 170 | 0.140 |
Why?
|
Diagnosis, Differential | 8 | 2020 | 12976 | 0.140 |
Why?
|
ROC Curve | 7 | 2024 | 3620 | 0.140 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 248 | 0.140 |
Why?
|
Exercise Tolerance | 2 | 2020 | 841 | 0.140 |
Why?
|
Heart Failure, Diastolic | 1 | 2018 | 77 | 0.140 |
Why?
|
Waiting Lists | 1 | 2022 | 777 | 0.140 |
Why?
|
Mass Media | 1 | 2020 | 301 | 0.140 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2020 | 511 | 0.140 |
Why?
|
Coronary Artery Bypass | 3 | 2014 | 2186 | 0.130 |
Why?
|
Radioactive Tracers | 2 | 2020 | 61 | 0.130 |
Why?
|
Treatment Outcome | 13 | 2024 | 65188 | 0.130 |
Why?
|
Disease-Free Survival | 4 | 2019 | 6832 | 0.130 |
Why?
|
Systole | 1 | 2018 | 935 | 0.130 |
Why?
|
Proportional Hazards Models | 9 | 2016 | 12509 | 0.130 |
Why?
|
Paraproteinemias | 2 | 2020 | 252 | 0.130 |
Why?
|
Algorithms | 6 | 2024 | 14071 | 0.130 |
Why?
|
Public Opinion | 1 | 2020 | 482 | 0.130 |
Why?
|
Calibration | 1 | 2018 | 814 | 0.130 |
Why?
|
Organometallic Compounds | 1 | 2019 | 644 | 0.120 |
Why?
|
Troponin | 2 | 2018 | 533 | 0.120 |
Why?
|
Tissue Distribution | 1 | 2019 | 2266 | 0.120 |
Why?
|
Obesity, Morbid | 1 | 2006 | 1292 | 0.120 |
Why?
|
Protein Folding | 1 | 2018 | 869 | 0.120 |
Why?
|
Fibrosis | 2 | 2023 | 2070 | 0.120 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2022 | 1339 | 0.120 |
Why?
|
Autoradiography | 1 | 2015 | 723 | 0.120 |
Why?
|
Decision Trees | 1 | 2016 | 509 | 0.120 |
Why?
|
Safety Management | 1 | 2020 | 763 | 0.110 |
Why?
|
Fee-for-Service Plans | 1 | 2019 | 716 | 0.110 |
Why?
|
North America | 4 | 2020 | 1285 | 0.110 |
Why?
|
Gated Blood-Pool Imaging | 2 | 2007 | 43 | 0.110 |
Why?
|
Age Distribution | 2 | 2018 | 2858 | 0.110 |
Why?
|
Vasomotor System | 1 | 2014 | 207 | 0.110 |
Why?
|
Safety | 2 | 2021 | 1157 | 0.110 |
Why?
|
Gadolinium | 1 | 2018 | 965 | 0.110 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2016 | 263 | 0.110 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3413 | 0.110 |
Why?
|
Remission Induction | 1 | 2019 | 2411 | 0.100 |
Why?
|
Pulse | 1 | 2013 | 215 | 0.100 |
Why?
|
Physics | 1 | 2013 | 92 | 0.100 |
Why?
|
Diabetes Mellitus | 3 | 2021 | 5891 | 0.100 |
Why?
|
Critical Pathways | 1 | 2016 | 474 | 0.100 |
Why?
|
Risk | 7 | 2021 | 9591 | 0.100 |
Why?
|
Blood Coagulation | 1 | 1998 | 1166 | 0.100 |
Why?
|
Benzoxazoles | 2 | 2024 | 91 | 0.100 |
Why?
|
Case-Control Studies | 4 | 2021 | 22223 | 0.100 |
Why?
|
Obesity | 6 | 2024 | 13076 | 0.100 |
Why?
|
Psoriasis | 1 | 2020 | 919 | 0.100 |
Why?
|
Fibroblasts | 1 | 2022 | 4159 | 0.100 |
Why?
|
Defibrillators, Implantable | 2 | 2018 | 1490 | 0.100 |
Why?
|
Lower Extremity | 1 | 2020 | 1226 | 0.090 |
Why?
|
Autopsy | 1 | 2015 | 1011 | 0.090 |
Why?
|
Young Adult | 5 | 2019 | 59889 | 0.090 |
Why?
|
Myocardial Stunning | 1 | 2011 | 67 | 0.090 |
Why?
|
Tissue Survival | 1 | 2011 | 121 | 0.090 |
Why?
|
Death | 2 | 2012 | 686 | 0.090 |
Why?
|
Europe | 4 | 2021 | 3423 | 0.090 |
Why?
|
Documentation | 2 | 2017 | 916 | 0.090 |
Why?
|
Arrhythmias, Cardiac | 4 | 2018 | 2247 | 0.090 |
Why?
|
Feasibility Studies | 3 | 2023 | 5302 | 0.090 |
Why?
|
Incidence | 5 | 2021 | 21480 | 0.090 |
Why?
|
Body Mass Index | 3 | 2014 | 13039 | 0.090 |
Why?
|
Physicians, Women | 2 | 2024 | 512 | 0.090 |
Why?
|
Hemodynamics | 3 | 2013 | 4184 | 0.090 |
Why?
|
Congresses as Topic | 1 | 2015 | 811 | 0.090 |
Why?
|
Physicians | 2 | 2022 | 4588 | 0.090 |
Why?
|
Kidney Failure, Chronic | 2 | 2015 | 2495 | 0.090 |
Why?
|
Artificial Intelligence | 5 | 2023 | 2659 | 0.090 |
Why?
|
Systems Integration | 3 | 2007 | 427 | 0.090 |
Why?
|
Regeneration | 1 | 2019 | 1517 | 0.080 |
Why?
|
Fasting | 1 | 2016 | 1606 | 0.080 |
Why?
|
Hospitals | 2 | 2020 | 3888 | 0.080 |
Why?
|
Biological Transport | 1 | 2014 | 2081 | 0.080 |
Why?
|
Coronary Aneurysm | 1 | 2012 | 233 | 0.080 |
Why?
|
Organ Specificity | 1 | 2014 | 1965 | 0.080 |
Why?
|
Boston | 3 | 2019 | 9338 | 0.080 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2018 | 1076 | 0.080 |
Why?
|
Causality | 1 | 2015 | 1248 | 0.080 |
Why?
|
Radiation Injuries | 2 | 2014 | 1181 | 0.080 |
Why?
|
Bone Marrow | 1 | 2019 | 2921 | 0.080 |
Why?
|
Canada | 2 | 2021 | 2119 | 0.080 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2021 | 2159 | 0.080 |
Why?
|
Kidney Transplantation | 1 | 2024 | 4270 | 0.080 |
Why?
|
Clinical Trials as Topic | 3 | 2020 | 8041 | 0.080 |
Why?
|
Risk Reduction Behavior | 1 | 2015 | 1123 | 0.080 |
Why?
|
Inpatients | 1 | 2020 | 2564 | 0.080 |
Why?
|
3-Iodobenzylguanidine | 1 | 2009 | 113 | 0.080 |
Why?
|
Comorbidity | 4 | 2018 | 10563 | 0.070 |
Why?
|
Nitrogen Radioisotopes | 2 | 2018 | 43 | 0.070 |
Why?
|
Adolescent | 6 | 2019 | 88835 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2020 | 3564 | 0.070 |
Why?
|
Survival Analysis | 5 | 2017 | 10070 | 0.070 |
Why?
|
Atrial Fibrillation | 2 | 2024 | 5189 | 0.070 |
Why?
|
Latin America | 2 | 2022 | 416 | 0.070 |
Why?
|
Multivariate Analysis | 7 | 2016 | 12056 | 0.070 |
Why?
|
Recovery of Function | 2 | 2017 | 2966 | 0.070 |
Why?
|
Ischemia | 3 | 2020 | 1909 | 0.070 |
Why?
|
Hospital Mortality | 2 | 2020 | 5343 | 0.070 |
Why?
|
Heart Valve Prosthesis | 1 | 2015 | 1466 | 0.070 |
Why?
|
Angiography | 1 | 2012 | 1581 | 0.070 |
Why?
|
Whole Body Imaging | 1 | 2009 | 281 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2018 | 1880 | 0.070 |
Why?
|
Bundle-Branch Block | 1 | 2008 | 280 | 0.070 |
Why?
|
Length of Stay | 1 | 2020 | 6485 | 0.070 |
Why?
|
Renal Dialysis | 1 | 2015 | 1799 | 0.060 |
Why?
|
Infection Control | 1 | 2013 | 983 | 0.060 |
Why?
|
Pattern Recognition, Automated | 1 | 2012 | 978 | 0.060 |
Why?
|
Catheter Ablation | 1 | 1998 | 2788 | 0.060 |
Why?
|
Chi-Square Distribution | 4 | 2016 | 3432 | 0.060 |
Why?
|
Thrombosis | 1 | 1998 | 2949 | 0.060 |
Why?
|
Myocardial Reperfusion | 1 | 2006 | 338 | 0.060 |
Why?
|
Sex Factors | 3 | 2024 | 10603 | 0.060 |
Why?
|
Hospitalization | 3 | 2019 | 10808 | 0.060 |
Why?
|
Spain | 2 | 2015 | 483 | 0.060 |
Why?
|
Cross-Sectional Studies | 4 | 2021 | 26318 | 0.060 |
Why?
|
Health Care Surveys | 2 | 2021 | 2424 | 0.050 |
Why?
|
Glucocorticoids | 1 | 2013 | 2132 | 0.050 |
Why?
|
Disease Susceptibility | 2 | 2020 | 1789 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2019 | 10429 | 0.050 |
Why?
|
Protein Binding | 1 | 2015 | 9296 | 0.050 |
Why?
|
Linear Models | 3 | 2016 | 5876 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9249 | 0.050 |
Why?
|
Apoptosis | 1 | 2019 | 9514 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2013 | 2643 | 0.050 |
Why?
|
Arterial Occlusive Diseases | 1 | 2007 | 729 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 2 | 2012 | 6499 | 0.050 |
Why?
|
Analysis of Variance | 2 | 2014 | 6203 | 0.050 |
Why?
|
Insurance Coverage | 1 | 2013 | 1944 | 0.050 |
Why?
|
Ultrasonography | 1 | 2015 | 5993 | 0.050 |
Why?
|
Mass Spectrometry | 2 | 2020 | 2194 | 0.050 |
Why?
|
Physician's Role | 1 | 2008 | 927 | 0.050 |
Why?
|
Benzothiazoles | 1 | 2022 | 246 | 0.050 |
Why?
|
Double-Blind Method | 3 | 2017 | 12437 | 0.050 |
Why?
|
Biomedical Research | 1 | 2017 | 3458 | 0.050 |
Why?
|
Oligonucleotides | 1 | 2024 | 561 | 0.050 |
Why?
|
Lung | 1 | 2019 | 10033 | 0.050 |
Why?
|
Leadership | 2 | 2020 | 1392 | 0.040 |
Why?
|
Phenotype | 1 | 2018 | 16721 | 0.040 |
Why?
|
Glomerular Filtration Rate | 3 | 2017 | 2233 | 0.040 |
Why?
|
Radiography | 1 | 2011 | 6919 | 0.040 |
Why?
|
International Agencies | 1 | 2021 | 240 | 0.040 |
Why?
|
Plaque, Atherosclerotic | 1 | 2011 | 1529 | 0.040 |
Why?
|
Radiology | 1 | 2013 | 2090 | 0.040 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2020 | 172 | 0.040 |
Why?
|
Decision Support Techniques | 1 | 2010 | 2003 | 0.040 |
Why?
|
Disease Management | 2 | 2020 | 2535 | 0.040 |
Why?
|
Myocardial Contraction | 1 | 2005 | 1515 | 0.040 |
Why?
|
Italy | 1 | 2021 | 854 | 0.040 |
Why?
|
Area Under Curve | 2 | 2014 | 1638 | 0.040 |
Why?
|
Organ Size | 1 | 2024 | 2260 | 0.040 |
Why?
|
Israel | 1 | 2021 | 725 | 0.040 |
Why?
|
Organizational Innovation | 1 | 2022 | 541 | 0.040 |
Why?
|
Dilatation | 1 | 2020 | 310 | 0.040 |
Why?
|
Arteries | 1 | 2023 | 1118 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2013 | 4058 | 0.040 |
Why?
|
Electroencephalography | 1 | 2014 | 6273 | 0.040 |
Why?
|
Technology | 1 | 2021 | 297 | 0.040 |
Why?
|
Pulmonary Embolism | 1 | 2012 | 2598 | 0.040 |
Why?
|
Referral and Consultation | 3 | 2015 | 3615 | 0.040 |
Why?
|
Prothrombin | 1 | 1998 | 193 | 0.040 |
Why?
|
Probability | 2 | 2014 | 2475 | 0.040 |
Why?
|
Pregnancy | 2 | 2013 | 30260 | 0.040 |
Why?
|
Age Factors | 3 | 2024 | 18380 | 0.040 |
Why?
|
Models, Cardiovascular | 2 | 2013 | 978 | 0.040 |
Why?
|
Fibrinolysis | 1 | 1998 | 331 | 0.030 |
Why?
|
Massachusetts | 3 | 2015 | 8875 | 0.030 |
Why?
|
Vascular Resistance | 2 | 2011 | 941 | 0.030 |
Why?
|
Communication | 3 | 2015 | 3916 | 0.030 |
Why?
|
Organophosphorus Compounds | 1 | 2018 | 209 | 0.030 |
Why?
|
Reference Standards | 1 | 2020 | 1013 | 0.030 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2003 | 1727 | 0.030 |
Why?
|
Oceania | 1 | 2016 | 21 | 0.030 |
Why?
|
Child, Preschool | 1 | 2019 | 42500 | 0.030 |
Why?
|
Delayed Diagnosis | 1 | 2020 | 452 | 0.030 |
Why?
|
Patient Participation | 2 | 2015 | 1455 | 0.030 |
Why?
|
Thrombin | 1 | 1998 | 602 | 0.030 |
Why?
|
Pyridazines | 1 | 2017 | 200 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2020 | 1740 | 0.030 |
Why?
|
Antithrombins | 1 | 1998 | 295 | 0.030 |
Why?
|
Automation | 1 | 2018 | 585 | 0.030 |
Why?
|
Electrophysiology | 1 | 1998 | 1263 | 0.030 |
Why?
|
Expert Testimony | 1 | 2017 | 266 | 0.030 |
Why?
|
Incidental Findings | 1 | 2020 | 697 | 0.030 |
Why?
|
Kidney | 2 | 2023 | 7066 | 0.030 |
Why?
|
Body Weight | 1 | 2006 | 4622 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 747 | 0.030 |
Why?
|
Health Services | 1 | 2020 | 756 | 0.030 |
Why?
|
Diastole | 1 | 2017 | 785 | 0.030 |
Why?
|
Sex Distribution | 2 | 2014 | 2263 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 790 | 0.030 |
Why?
|
Asia | 1 | 2016 | 628 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2021 | 21056 | 0.030 |
Why?
|
Nitroglycerin | 1 | 2015 | 331 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2019 | 1560 | 0.030 |
Why?
|
Observer Variation | 2 | 2013 | 2615 | 0.030 |
Why?
|
Computer Systems | 1 | 2015 | 466 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2020 | 1394 | 0.030 |
Why?
|
Africa | 1 | 2016 | 725 | 0.030 |
Why?
|
Logistic Models | 3 | 2016 | 13266 | 0.030 |
Why?
|
Diffusion of Innovation | 1 | 2018 | 721 | 0.030 |
Why?
|
Occupational Health | 1 | 2020 | 813 | 0.030 |
Why?
|
Animals | 5 | 2019 | 168764 | 0.030 |
Why?
|
Radiotherapy | 1 | 2020 | 1494 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2020 | 2865 | 0.030 |
Why?
|
Japan | 1 | 2017 | 1415 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2018 | 1528 | 0.030 |
Why?
|
Radiation, Ionizing | 1 | 2014 | 249 | 0.030 |
Why?
|
Tachycardia, Ventricular | 2 | 2013 | 1310 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2015 | 955 | 0.030 |
Why?
|
Angioplasty | 1 | 2015 | 352 | 0.030 |
Why?
|
Databases, Factual | 2 | 2018 | 8067 | 0.020 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2015 | 276 | 0.020 |
Why?
|
Propensity Score | 1 | 2019 | 1968 | 0.020 |
Why?
|
Pacemaker, Artificial | 1 | 2017 | 827 | 0.020 |
Why?
|
Acute Disease | 2 | 2012 | 7232 | 0.020 |
Why?
|
Statistics, Nonparametric | 2 | 2009 | 2844 | 0.020 |
Why?
|
Sulfonic Acids | 1 | 2011 | 103 | 0.020 |
Why?
|
Child | 1 | 2019 | 80564 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2017 | 2108 | 0.020 |
Why?
|
Reference Values | 1 | 2018 | 4908 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2013 | 586 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2015 | 770 | 0.020 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2011 | 282 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 2014 | 1105 | 0.020 |
Why?
|
Occupational Exposure | 1 | 2020 | 1805 | 0.020 |
Why?
|
Acetates | 1 | 2011 | 313 | 0.020 |
Why?
|
Internationality | 1 | 2015 | 1007 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2012 | 999 | 0.020 |
Why?
|
Acetamides | 1 | 2011 | 260 | 0.020 |
Why?
|
Cardiotonic Agents | 1 | 2012 | 538 | 0.020 |
Why?
|
Pericardium | 1 | 2014 | 679 | 0.020 |
Why?
|
Alleles | 1 | 2020 | 6897 | 0.020 |
Why?
|
Data Collection | 1 | 2018 | 3318 | 0.020 |
Why?
|
International Cooperation | 1 | 2015 | 1432 | 0.020 |
Why?
|
Carbon Isotopes | 1 | 2009 | 451 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2020 | 4528 | 0.020 |
Why?
|
Health Personnel | 1 | 2022 | 3390 | 0.020 |
Why?
|
Zebrafish | 1 | 2019 | 3036 | 0.020 |
Why?
|
Postoperative Care | 1 | 2014 | 1470 | 0.020 |
Why?
|
Negotiating | 1 | 2008 | 152 | 0.020 |
Why?
|
Kidney Function Tests | 1 | 2009 | 683 | 0.020 |
Why?
|
Syncope | 1 | 2010 | 429 | 0.020 |
Why?
|
Models, Animal | 1 | 2013 | 2120 | 0.020 |
Why?
|
Data Interpretation, Statistical | 2 | 2011 | 2686 | 0.020 |
Why?
|
Inflammation | 2 | 2018 | 10850 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2012 | 1315 | 0.020 |
Why?
|
Genotype | 1 | 2020 | 13024 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2012 | 2352 | 0.020 |
Why?
|
Job Satisfaction | 1 | 2008 | 549 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2013 | 1880 | 0.010 |
Why?
|
Prejudice | 1 | 2008 | 567 | 0.010 |
Why?
|
Anticholesteremic Agents | 1 | 2011 | 970 | 0.010 |
Why?
|
Disease Progression | 1 | 2021 | 13632 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5526 | 0.010 |
Why?
|
Odds Ratio | 1 | 2016 | 9649 | 0.010 |
Why?
|
Mentors | 1 | 2008 | 671 | 0.010 |
Why?
|
Rest | 1 | 2008 | 942 | 0.010 |
Why?
|
Cholesterol | 1 | 2011 | 2898 | 0.010 |
Why?
|
Sulfonamides | 1 | 2011 | 1984 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2007 | 2910 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2012 | 1938 | 0.010 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2003 | 580 | 0.010 |
Why?
|
Recurrence | 1 | 2013 | 8501 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2005 | 2229 | 0.010 |
Why?
|
Radionuclide Angiography | 1 | 1999 | 23 | 0.010 |
Why?
|
Acute Coronary Syndrome | 1 | 2012 | 2184 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18293 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2011 | 3850 | 0.010 |
Why?
|
Rats | 1 | 2015 | 23707 | 0.010 |
Why?
|
Chronic Disease | 1 | 2013 | 9347 | 0.010 |
Why?
|
Mutation | 1 | 2020 | 30198 | 0.010 |
Why?
|
Brain | 1 | 2022 | 27171 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2008 | 3925 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2003 | 15747 | 0.000 |
Why?
|